{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:39:42Z","timestamp":1790894382237,"version":"4.1.0"},"reference-count":50,"publisher":"The Journal of Rheumatology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2025,12,2]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Systemic juvenile idiopathic arthritis (sJIA) is a chronic inflammatory disease characterized by systemic features and arthritis. Macrophage activation syndrome (MAS) is a severe complication of sJIA often involving the liver. MAS confined predominantly to the liver, causing severe hepatitis, has been increasingly recognized. When liver MAS is the primary manifestation, significant hepatic injury can occur; therefore, differentiation from other forms of sJIA-related liver involvement, which may warrant distinct treatment approaches, is required. This study examined liver pathology in patients with sJIA-MAS and explored potential mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective case series analyzed data from 4 patients with sJIA-MAS who presented with liver dysfunction and underwent core liver biopsies at Cincinnati Children\u2019s Hospital Medical Center (2019-2024).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four patients (age range 4-15 years) had elevated transaminases, with 1 meeting MAS criteria and 3 diagnosed with subclinical MAS. Liver biopsies showed portal and sinusoidal inflammatory infiltrates of CD3+ CD8+ T cells and CD163+ macrophages, with extensive hepatocellular damage, including centrilobular parenchymal collapse, multifocal necrosis, and lymphocyte-mediated bile duct injury. One case revealed features of venoocclusive disease, a novel finding. Elevated serum chemokine (C-X-C motif) ligand 9 (CXCL9) and rapid response to emapalumab (anti\u2013interferon \u03b3 [anti\u2013IFN-\u03b3]) in all patients suggested IFN-\u03b3\u2013driven liver pathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study underscores the critical roles of CD8+ T cells, macrophages, and IFN-\u03b3 in sJIA-MAS hepatitis. Future research should explore whether serum biomarkers of IFN-\u03b3 activity can differentiate sJIA-MAS from other liver pathologies, such as drug-induced liver injury (methotrexate- or anakinra-induced) and hepatic steatosis, to guide tailored therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.2025-0699","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:20:15Z","timestamp":1765804815000},"page":"669-678","source":"Crossref","is-referenced-by-count":2,"title":["Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome"],"prefix":"10.3899","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4770-7383","authenticated-orcid":false,"given":"Esraa","family":"Eloseily","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanna","family":"Romankevych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4950-2199","authenticated-orcid":false,"given":"Taskin","family":"Sabit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7341-1642","authenticated-orcid":false,"given":"Lara","family":"Berklite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6214-9167","authenticated-orcid":false,"given":"Sarangarajan","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6535-6564","authenticated-orcid":false,"given":"Paul","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Henrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Huggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5923-7051","authenticated-orcid":false,"given":"Grant","family":"Schulert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Grom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"2026061213100664000_53.6.669.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.68"},{"key":"2026061213100664000_53.6.669.2","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2026061213100664000_53.6.669.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-225853"},{"key":"2026061213100664000_53.6.669.4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","article-title":"2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation collaborative initiative","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026061213100664000_53.6.669.5","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1111\/j.1440-1754.2011.02213.x","article-title":"Acute liver failure in young children with systemic-onset juvenile idiopathic arthritis without macrophage activation syndrome: report of two cases","volume":"48","author":"Hiejima","year":"2012","journal-title":"J Paediatr Child Health"},{"key":"2026061213100664000_53.6.669.6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1546-0096-7-21","article-title":"Acute hepatitis in three patients with systemic juvenile idiopathic arthritis taking interleukin-1 receptor antagonist","volume":"7","author":"Canna","year":"2009","journal-title":"Pediatr Rheumatol Online J"},{"key":"2026061213100664000_53.6.669.7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.reuma.2013.09.001","article-title":"Nodular regenerative hyperplasia of the liver as a complication of long-standing systemic-onset juvenile idiopathic arthritis","volume":"10","author":"Sifuentes Giraldo","year":"2014","journal-title":"Reumatol Clin"},{"key":"2026061213100664000_53.6.669.8","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180168"},{"key":"2026061213100664000_53.6.669.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.22416"},{"key":"2026061213100664000_53.6.669.10","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J Rheumatol"},{"key":"2026061213100664000_53.6.669.11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-2997"},{"key":"2026061213100664000_53.6.669.12","doi-asserted-by":"crossref","first-page":"e0226043","DOI":"10.1371\/journal.pone.0226043","article-title":"The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis","volume":"14","author":"Prencipe","year":"2019","journal-title":"PLoS One"},{"key":"2026061213100664000_53.6.669.13","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223739"},{"key":"2026061213100664000_53.6.669.14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1998.00377.x"},{"key":"2026061213100664000_53.6.669.15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/15513819609168681","article-title":"Histopathology of the liver in histiocytosis syndromes","volume":"16","author":"Favara","year":"1996","journal-title":"Pediatr Pathol Lab Med"},{"key":"2026061213100664000_53.6.669.16","first-page":"772","article-title":"Histopathological features of liver tissue biopsies in SJIA patients with and without clinical macrophage activation syndrome [abstract]","volume":"76","author":"Eloseily","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026061213100664000_53.6.669.17","unstructured":"Eloseily E , Sabit T , Berklite L , Schulert G , Grom A. O19 Spatial transcriptomic profiling reveals interferon activation and CD8+ T cell dominance in systemic juvenile idiopathic arthritis-macrophage activation syndrome liver inflammation [abstract]. In: Proceedings of the 32nd European paediatric rheumatology congress, 2025, Sept 17-20; Helsinki: Pediatr Rheumatol; 2025:23."},{"key":"2026061213100664000_53.6.669.18","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002611"},{"key":"2026061213100664000_53.6.669.19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acr.23277","article-title":"Effect of biologic therapy on clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis","volume":"70","author":"Schulert","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2026061213100664000_53.6.669.20","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jhep.2006.03.003","article-title":"Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis","volume":"44","author":"Bihl","year":"2006","journal-title":"J Hepatol"},{"key":"2026061213100664000_53.6.669.21","doi-asserted-by":"crossref","first-page":"rky034.049","DOI":"10.1093\/rap\/rky034.049","article-title":"86. Intravenous anakinra treatment in a rare case of macrophage activation syndrome presenting as fulminant liver failure","volume":"2","author":"Ghuman","year":"2018","journal-title":"Rheumatol Adv Pract"},{"key":"2026061213100664000_53.6.669.22","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1111\/tri.12176","article-title":"Liver transplantation for acute liver failure caused by macrophage activation syndrome","volume":"26","author":"Orr","year":"2013","journal-title":"Transpl Int"},{"key":"2026061213100664000_53.6.669.23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00489"},{"key":"2026061213100664000_53.6.669.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.11.011"},{"key":"2026061213100664000_53.6.669.25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0014-4800(03)00094-7","article-title":"Role of macrophages and stellate cells in the pathogenesis of veno-occlusive disease: an electron microscopic case study","volume":"75","author":"Tang","year":"2003","journal-title":"Exp Mol Pathol"},{"key":"2026061213100664000_53.6.669.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(70)80324-9"},{"key":"2026061213100664000_53.6.669.27","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0022-3476(85)80445-5","article-title":"JRA and hyperphosphataemia","volume":"107","author":"Jacobs","year":"1985","journal-title":"J Pediatr"},{"key":"2026061213100664000_53.6.669.28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2169\/internalmedicine.34.89","article-title":"Adult-onset Still\u2019s disease with submassive hepatic necrosis","volume":"34","author":"Takami","year":"1995","journal-title":"Intern Med"},{"key":"2026061213100664000_53.6.669.29","first-page":"1093","article-title":"Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still\u2019s disease","volume":"30","author":"Ogata","year":"2003","journal-title":"J Rheumatol"},{"key":"2026061213100664000_53.6.669.30","doi-asserted-by":"publisher","DOI":"10.1002\/art.30128"},{"key":"2026061213100664000_53.6.669.31","unstructured":"LiverTox: clinical and research information on drug-induced liver injury. Bethesda, Maryland: National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"key":"2026061213100664000_53.6.669.32","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/phar.1677","article-title":"Anakinra-induced acute liver failure in an adolescent patient with Still\u2019s disease","volume":"36","author":"Taylor","year":"2016","journal-title":"Pharmacotherapy"},{"key":"2026061213100664000_53.6.669.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112802"},{"key":"2026061213100664000_53.6.669.34","first-page":"964828","article-title":"Tocilizumab-induced acute liver injury in adult onset Still\u2019s disease","volume":"2013","author":"Drepper","year":"2013","journal-title":"Case Rep Hepatol"},{"key":"2026061213100664000_53.6.669.35","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/rheumatology\/kex221","article-title":"Toxic drug-induced liver failure during therapy of rheumatoid arthritis with tocilizumab subcutaneously: a case report","volume":"56","author":"Anger","year":"2017","journal-title":"Rheumatology"},{"key":"2026061213100664000_53.6.669.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2011.00793.x"},{"key":"2026061213100664000_53.6.669.37","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes397"},{"key":"2026061213100664000_53.6.669.38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220578"},{"key":"2026061213100664000_53.6.669.39","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12501"},{"key":"2026061213100664000_53.6.669.40","first-page":"149","article-title":"The toxicity of nonsteroidal antiinflammatory drugs in juvenile rheumatoid arthritis","volume":"9","author":"Barron","year":"1982","journal-title":"J Rheumatol"},{"key":"2026061213100664000_53.6.669.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70448-1"},{"key":"2026061213100664000_53.6.669.42","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12098-019-02912-9","article-title":"Cyclosporine in resistant systemic arthritis\u2014a cheaper alternative to biologics","volume":"86","author":"Pal","year":"2019","journal-title":"Indian J Pediatr"},{"key":"2026061213100664000_53.6.669.43","first-page":"330","article-title":"Long-term effects of azathioprine therapy for juvenile rheumatoid arthritis","volume":"99","author":"Lin","year":"2000","journal-title":"J Formos Med Assoc"},{"key":"2026061213100664000_53.6.669.44","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090874"},{"key":"2026061213100664000_53.6.669.45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/mr\/roab055","article-title":"Tacrolimus as an alternative treatment for patients with juvenile idiopathic arthritis","volume":"32","author":"Yamazaki","year":"2022","journal-title":"Mod Rheumatol"},{"key":"2026061213100664000_53.6.669.46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S1516-31802003000300006","article-title":"Treatment of refractory juvenile idiopathic arthritis via pulse therapy using methylprednisolone and cyclophosphamide","volume":"121","author":"de Castro","year":"2003","journal-title":"Sao Paulo Med J"},{"key":"2026061213100664000_53.6.669.47","first-page":"132","article-title":"Multiple autoimmune syndrome","volume":"5","author":"Cojocaru","year":"2010","journal-title":"Maedica"},{"key":"2026061213100664000_53.6.669.48","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.021360"},{"key":"2026061213100664000_53.6.669.49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/RHU.0b013e318188b1df","article-title":"Development of autoimmune hepatitis in a child with systemic-onset juvenile idiopathic arthritis during therapy with etanercept","volume":"14","author":"Fathalla","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"2026061213100664000_53.6.669.50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1521837113"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2025-0699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T20:10:56Z","timestamp":1781295056000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2025-0699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.3899\/jrheum.2025-0699"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2025-0699","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]}}}